In many scleroderma tissues, there are also a decrease in TOP1 catalytic activity and an increase in TOP1 SUMOylation [37], but the nature of this SUMOylation and the significance of these phenomena to scleroderma pathogenesis are yet to be defined. Here, TOP1 is linked to scleroderma.